Goldman Julie L, Ziegler Craig, Burckardt Elizabeth M
Department of Otolaryngology-Head and Neck Surgery and Communicative Disorders, University of Louisville School of Medicine, Louisville, Kentucky, U.S.A.
University of Louisville Office of Graduate Medical Education, University of Louisville School of Medicine, Louisville, Kentucky, U.S.A.
Laryngoscope. 2018 Jan;128(1):264-268. doi: 10.1002/lary.26719. Epub 2017 Jun 13.
OBJECTIVES/HYPOTHESIS: To determine if otolaryngologists at a single children's hospital were adherent to the boxed warning for codeine use in post-tonsillectomy patients and the implications for practice patterns.
Case series with chart review.
Charts from all patients undergoing adenotonsillectomy at a single children's hospital from January 1, 2010 through December 31, 2015 were analyzed and stratified according to date (pre- or post-boxed warning) and practitioner type (academic otolaryngologists [AO] vs. nonacademic otolaryngologists [NAO]). Demographic data, surgical technique, method of removal, narcotic prescriptions (dosage and drug), and complications were recorded. Fisher exact test was used to determine the level of significance in prescription rates pre- and postwarning. SPSS version 22 was used for statistical analysis, with P < .05 indicating statistical significance.
There were 2,749 children undergoing adenotonsillectomy during the study period, with 1,239 AOs and 1,510 NAOs. There was a distinct downward trend in codeine prescriptions before and after the warning, with the AO group reaching zero sooner than the NAO group. There was a 5% decrease in discharge narcotic prescriptions given postwarning (P < .001), but no significant difference in postoperative emergency department visits or pain-related complications when comparing the two time periods.
Codeine use for management of pediatric post-tonsillectomy pain was essentially zero after issuance of the boxed warning. Total narcotic use decreased significantly without increase in pain- or medication-related complications. Future research should focus on identifying markers of increased susceptibility to adverse medication events and determining the safest options for pain management.
目的/假设:确定一家儿童医院的耳鼻喉科医生是否遵守了可待因用于扁桃体切除术后患者的盒装警告以及对实践模式的影响。
带有病历回顾的病例系列研究。
分析了2010年1月1日至2015年12月31日在一家儿童医院接受腺样体扁桃体切除术的所有患者的病历,并根据日期(盒装警告之前或之后)和从业者类型(学术耳鼻喉科医生[AO]与非学术耳鼻喉科医生[NAO])进行分层。记录人口统计学数据、手术技术、切除方法、麻醉处方(剂量和药物)以及并发症。采用Fisher精确检验确定警告前后处方率的显著水平。使用SPSS 22版进行统计分析,P <.05表示具有统计学意义。
研究期间有2749名儿童接受了腺样体扁桃体切除术,其中AO组1239人,NAO组1510人。警告前后可待因处方有明显下降趋势,AO组比NAO组更快降至零。警告后出院麻醉处方减少了5%(P <.001),但比较两个时间段时,术后急诊科就诊或疼痛相关并发症无显著差异。
发出盒装警告后,可待因用于小儿扁桃体切除术后疼痛管理基本为零。总麻醉药物使用显著减少,且疼痛或药物相关并发症未增加。未来研究应专注于识别药物不良事件易感性增加的标志物,并确定疼痛管理的最安全选择。
4。《喉镜》,2018年,第128卷:264 - 268页。